Realtime | Geld | Brief | Zeit |
---|---|---|---|
32,200 | 33,000 | 09.04. | |
32,400 | 32,800 | 09.04. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
---|---|---|---|---|
02.04. | Former LivaNova CEO to take corner office at Enovis | 2 | MassDevice | |
26.03. | LivaNova PLC: LivaNova to Announce First-Quarter 2025 Results | 1.353 | Business Wire | |
18.03. | Jefferies cuts Livanova stock price target to $74 from $80 | 1 | Investing.com | |
18.03. | Barclays maintains Livanova stock with $56 target, cites clarity | 4 | Investing.com | |
LIVANOVA Aktie jetzt für 0€ handeln | ||||
17.03. | Needham maintains Livanova buy rating, $64 target amid liability | 1 | Investing.com | |
10.03. | Goldman Sachs maintains Livanova buy rating, $55 target | 5 | Investing.com | |
26.02. | Mizuho cuts Livanova stock target to $60, maintains Outperform | 4 | Investing.com | |
26.02. | Livanova stock rating downgraded at Wolfe Research | 1 | Investing.com | |
26.02. | Stifel cuts Livanova stock price target to $60 from $72 | 1 | Investing.com | |
25.02. | LivaNova PLC - 10-K, Annual Report | - | SEC Filings | |
25.02. | LivaNova PLC reports mixed Q4 results; initiates FY25 outlook | 3 | Seeking Alpha | |
25.02. | LivaNova PLC - 8-K, Current Report | - | SEC Filings | |
21.02. | LivaNova PLC: LivaNova to Present at the Barclays Global Healthcare Conference | 280 | Business Wire | |
21.01. | LivaNova PLC: LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results | 400 | Business Wire | |
06.01. | LivaNova PLC: LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer | 506 | Business Wire | |
18.12.24 | LivaNova PLC: RECOVER Clinical Study Shows Meaningful Benefits of LivaNova's VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression | 343 | Business Wire | |
05.12.24 | LivaNova PLC: LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting | 259 | Business Wire | |
19.11.24 | Livanova's aura6000 Shows Promise for Obstructive Sleep Apnea | 6 | Mexico Business News | |
18.11.24 | LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint | 2 | Zacks | |
14.11.24 | LivaNova PLC: LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences | 224 | Business Wire |